Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1842 Records) |
Query Trace: Adenocarcinoma and EGFR[original query] |
---|
Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection. Cancers 2023 12 15 (23): . Hwa Kyung Park, Yoo Duk Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Young Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae |
Clonality Analysis for the Relationship between the Pulmonary Combined Neuroendocrine Carcinoma and "the So-Called Reported Histologic Transformation". Cancers 2023 12 15 (23): . Haiyue Wang, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Weijing Cai, Dongmei L |
Predictive Value of EGFR Mutation Status for First-Line Tyrosine Kinase Inhibitor Treatment in Patients with Advanced Lung Cancer. Alternative therapies in health and medicine 2023 12 . Youqin Xie, Jinliang Chen, Wen Zhu, Zhihui Ye, Xuedong |
Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis. Frontiers in medicine 2023 12 10 1268846. Jianhao Qiu, Zheng Ma, Rongyang Li, Chenghao Qu, Kun Wang, Binyan Liu, Yu Tian, Hui Ti |
Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 12 187 107439. Lei Wang, Meng Diao, Zheng Zhang, Minlin Jiang, Shifu Chen, Deping Zhao, Zhenguo Liu, Caicun Zh |
NOS3 and CTH gene mutations as new molecular markers for detection of lung adenocarcinoma. PeerJ 2023 12 11 e16209. Iman Abdullah Ramadhan, Luqman Rahman Sulaiman, Abbas Sali |
Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2023 12 . Masaya Aoki, Ryo Miyata, Go Kamimura, Aya Harada Takeda, Takayuki Suetsugu, Keiko Mizuno, Kazuhiro Ue |
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer. JAMA network open 2023 12 6 (12): e2347700. Tomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, Toshihide Yokoyama, Atsushi Nakamura, Takaaki Tokito, Tatsuro Okamoto, Hiroaki Akamatsu, Masahide Oki, Yuki Sato, Kazunori Tobino, Satoshi Ikeda, Masahide Mori, Chihiro Mimura, Ken Maeno, Satoru Miura, Toshiyuki Harada, Kunihiro Nishimura, Manabu Hiraoka, Hirotsugu Kenmotsu, Junya Fujimoto, Mototsugu Shimokawa, Nobuyuki Yamamoto, Kazuhiko Nakaga |
Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
Genetic characteristics of lung adenocarcinoma with ground-glass opacity component. Journal of thoracic disease 2023 12 15 (11): 6106-6114. Weipeng Zhu, Na Bai, Jiashun Cao, Fan Yang, Donghong Ch |
Real-World Evidence of EGFR Targeted Therapy in NSCLC- A Brief Report of Decade Long Single Center Experience. JTO clinical and research reports 2023 11 4 (11): 100566. Anuradha Chougule, Pratik Chandrani, Vanita Noronha, Priyanka Pange, Shrutikaa Kale, Ankita Nikam, Kavya Nambiar, Dipika Marchande, Arpana Durve, Vinod Gupta, Vinita Jagtap, Priyanka Tiwrekar, Nandini Menon, Amit Joshi, Rajeev Kaushal, Trupti Pai, Vijay Maruti Patil, Amit Dutt, Shripad Dinanath Banavali, Kumar Prabha |
Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report. Case reports in oncology 2023 11 16 (1): 1384-1389. Andrew Davis, Sophia Jarrar, Christine Ciun |
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinoma. Translational lung cancer research 2023 11 12 (10): 2001-2014. Tetsuya Isaka, Yohei Miyagi, Tomoyuki Yokose, Haruhiro Saito, Rika Kasajima, Kozue Watabe, Naoko Shigeta, Noritake Kikunishi, Shunsuke Shigefuku, Kotaro Murakami, Hiroyuki Adachi, Takuya Nagashima, Hiroyuki I |
Prediction of EGFR mutation status in lung adenocarcinoma based on F-FDG PET/CT radiomic features. American journal of nuclear medicine and molecular imaging 2023 11 13 (5): 230-244. Jian-Ling Tan, Liang Xia, Su-Guang Sun, Hui Zeng, Di-Yu Lu, Xiao-Jie Che |
EGFR Mutated Non-Small Cell Lung Cancer Complicated by Cancer Associated Ischemic Stroke. Maedica 2023 11 18 (3): 515-518. Manato Taguchi, Takeshi Kawakami, Sachie Hasegawa, Shinichiro Okauchi, Gen Ohara, Hiroaki Satoh, Nubuyuki Hiza |
Prognostic Outcomes and Recurrence Patterns in Resected Stage I Lung Adenocarcinoma Harboring Atypical Epidermal Growth Factor Receptor Mutation. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2023 11 . Tao Chen, Jialiang Wen, Yingze Li, Jiajun Deng, Yifan Zhong, Likun Hou, Yunlang She, Dong Xie, Chang Ch |
Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma. Clinical radiology 2023 11 . Z Huang, X Tu, T Yu, Z Zhan, Q Lin, X Hua |
Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation. Clinical lung cancer 2023 11 . Kazuki Hayasaka, Haruna Takeda, Akira Sakurada, Yuki Matsumura, Jiro Abe, Satoshi Shiono, Hirotsugu Notsuda, Hiroyuki Suzuki, Makoto Endo, Hozumi Motohashi, Yoshinori Oka |
Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study. Journal of thoracic disease 2023 11 15 (10): 5648-5657. Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying |
Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 1 . Luoqi Weng, Yilun Xu, Yuhan Chen, Chengshui Chen, Qinqing Qian, Jie Pan, Huang |
Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib. Therapeutic advances in medical oncology 2024 1 16 17588359231220606. Jia-Jun Wu, Jeng-Sen Tseng, Zhe-Rong Zheng, Cheng-Hsiang Chu, Kun-Chieh Chen, Mong-Wei Lin, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Tsung-Ying Yang, Sung-Liang Yu, Jin-Shing Chen, Chao-Chi Ho, Gee-Chen Cha |
Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment. Frontiers in oncology 2024 1 13 1308313. Yongxia Chen, Mengye He, Zhengfeng Dai, Yina Wang, Jing Chen, Xiaoting Wang, Xiao Dong, Jianfei Huang, Jian Ruan, Xiaochen Zhang, Peng Shen, Yunlu J |
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer; Single-Institution Experience. Cancer research and treatment 2024 1 . So Heun Lee, Hyehyun Jeong, Deok Hoon Kim, Se Jin Jang, Sang-We Kim, Shinkyo Yoon, Dae Ho L |
Using Multi-phase CT Radiomics Features to Predict EGFR Mutation Status in Lung Adenocarcinoma Patients. Academic radiology 2024 1 . Guojin Zhang, Qiong Man, Lan Shang, Jing Zhang, Yuntai Cao, Shenglin Li, Rong Qian, Jialiang Ren, Hong Pu, Junlin Zhou, Zhuoli Zhang, Weifang Ko |
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer science 2024 1 . Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizu |
Clinicopathological significances of cribriform pattern in lung adenocarcinoma. Pathology, research and practice 2024 1 253 155035. Jung-Soo Pyo, Byoung-Hoon Lee, Kyueng-Whan Min, Nae Yu K |
The detection of PD-L1 expression on liquid-based cytology in pleural effusion of lung adenocarcinoma and its prognostic evaluation: Between paired liquid-based cytology and cell block samples. Diagnostic cytopathology 2024 1 . Haiyue Ma, Jia Jia, Zihan Sun, Xiaoyue Xiao, Shuo Liang, Linlin Zhao, Zhihui Zha |
The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma. Journal of cancer research and therapeutics 2024 1 . Mukremin Uysal, Ismail Beypinar, Murat Ar |
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: